Mainz Liabilities And Stockholders Equity from 2010 to 2024
| MYNZ Stock | USD 0.22 0.04 15.38% |
Liabilities And Stockholders Equity | First Reported 2010-12-31 | Previous Quarter 15.4 M | Current Value 10.4 M | Quarterly Volatility 6.5 M |
Check Mainz Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mainz Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.1 M or Interest Expense of 419.9 K, as well as many indicators such as Price To Sales Ratio of 19.99, Dividend Yield of 0.0 or PTB Ratio of 6.09. Mainz financial statements analysis is a perfect complement when working with Mainz Biomed Valuation or Volatility modules.
Mainz | Liabilities And Stockholders Equity |
Latest Mainz Biomed's Liabilities And Stockholders Equity Growth Pattern
Below is the plot of the Liabilities And Stockholders Equity of Mainz Biomed BV over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Mainz Biomed's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mainz Biomed's overall financial position and show how it may be relating to other accounts over time.
| Liabilities And Stockholders Equity | 10 Years Trend |
|
Liabilities And Stockholders Equity |
| Timeline |
Mainz Liabilities And Stockholders Equity Regression Statistics
| Arithmetic Mean | 4,258,753 | |
| Geometric Mean | 1,557,903 | |
| Coefficient Of Variation | 152.27 | |
| Mean Deviation | 5,201,790 | |
| Median | 715,959 | |
| Standard Deviation | 6,484,920 | |
| Sample Variance | 42.1T | |
| Range | 19.6M | |
| R-Value | 0.72 | |
| Mean Square Error | 22.1T | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 1,037,309 | |
| Total Sum of Squares | 588.8T |
Mainz Liabilities And Stockholders Equity History
About Mainz Biomed Financial Statements
Mainz Biomed investors use historical fundamental indicators, such as Mainz Biomed's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mainz Biomed. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Liabilities And Stockholders Equity | 15.4 M | 10.4 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Mainz Stock Analysis
When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.